Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents

D Suez, G Krivan, S Jolles, M Stein, S Gupta, K Paris, P.M. van Hagen, N Brodszki, W Engl, H Leibl, B McCoy, L Yel

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1057-1065
Number of pages9
JournalImmunotherapy
Volume11
Issue number12
DOIs
Publication statusPublished - 2019

Cite this